The FDA-approved smoking cessation pill, varenicline, is emerging as a crucial tool in the battle against nicotine addiction, especially among teens and young adults.Recent clinical trials reveal that participants taking this twice-daily pill had a staggering threefold increase in success rates for quitting vaping when compared to those given a placebo.